Notas de prensa

  • 11 de diciembre de 2017
  • 227

Envigo implements first-in-class surgical model tracking system

Groundbreaking software provides real-time tracking, accuracy and data access

East Millstone, NJ, USA, December 11, 2017: Envigo, a leading provider of nonclinical contract research services and research models, announced today the implementation of a first-in-class surgical model tracking system, designed to track and monitor the entire spectrum of surgical model development – enabling critically required efficiencies while enhancing animal welfare. The system, which tracks both animals and surgeons, works by implanting RFID microchips in each surgically-modified animal model allowing Envigo to record real-time, accurate data on animals in surgery. This system includes proper surgical information on the weight, date of birth of animals, surgical preparation; catheters and implants; analgesics and anaesthetics; length of surgery; post-operative care and recovery, and finally, inventory and shipments. The major benefits for researchers are a reduction of the number of rodents used in research and improvements in surgery and study accuracy.

The new technology is designed to limit human error by permanently identifying each rodent’s status through all stages of the surgical process, and to provide Envigo with better access to inventory, effective metrics on particular aspects of surgical procedures, and a mechanism for ensuring that the right medications are taken at the right time. Additionally, this system adds an extra layer of quality assurance, meaning that customers can be sure the right model has been supplied for surgical procedures.

Finally, by creating a digital repository, the system streamlines the regulatory compliance challenges of existing electronic documentation approaches, including failure to compile required data.

Brad Gien, Head of North America Surgery at Envigo commented: “The innovative tracking system is the first software tracking system to be introduced into the surgical space. The initiative forms part of our company’s commitment to the 3Rs strategy on animal testing – refine, reduce and replace. The technology refines surgical outcomes and animal health. In terms of efficiencies, our own studies have shown that the system is estimated to reduce the number of animals required for surgery and inventory. It is the first ever effective serialization system for rodents and serves to improve the outcomes of surgical services for the pre-clinical research industry.”

Destacadas

  • GENESIS Biomed consolidates its position as a key player in the growth of the Spanish health innovation ecosystem

    Press Office Comunication

    GENESIS Biomed consolidates its position as a key player in the growth of the Spanish health innovation ecosystem

    Leer más
  • Docentes de la Universidad Internacional de Valencia destacan la búsqueda de apoyo como elemento clave en la recuperación del bienestar tras la pérdida

    Farmanews Farmanews

    Docentes de la Universidad Internacional de Valencia destacan la búsqueda de apoyo como elemento clave en la recuperación del bienestar tras la pérdida

    Leer más
  • Un estudio clínico español demuestra por primera vez la eficacia de la terapia génica en pacientes con anemia de Fanconi

    Farmanews Farmanews

    Un estudio clínico español demuestra por primera vez la eficacia de la terapia génica en pacientes con anemia de Fanconi

    Leer más

Newsletter

Suscríbete para conocer las novedades del mundo farmacéutico y sanitario.

¿Qué es?

FarmaNews pone a disposición de los medios y departamentos de comunicación, un canal para publicar notas de prensa y convocatorias del mundo sanitario y farmacéutico.

Contacto

Avda. Mare de Déu de Lourdes, 108,
08757, Corbera de Llobregat
(Barcelona), España